Mahana Therapeutics

Mahana Therapeutics Focuses on Developing Digital Therapeutics for Children and Adults with Gastrointestinal Diseases and Conditions, Aiming to Help Patients with Chronic Illnesses Lead More Fulfilling Lives. The company’s first product, Mahana IBS, is the first FDA-approved digital therapeutic for IBS treatment, offering cognitive behavioral therapy (CBT) for adult IBS patients. Guided by rigorous clinical evidence and patient experiences, the company is a diverse combination of healthcare and technology entrepreneurs, gastroenterologists, psychologists, behavioral scientists, and passionate patients, all dedicated to improving the health and quality of life for individuals with chronic gastrointestinal conditions.